Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease
Introduction: Immune mediated liver diseases entail a broad category which are associated with increased morbidity and mortality amongst the paediatric population. Programmed Death 1 (PD1) is an inhibitory receptor mainly expressed by T cells, and when activated shed into plasma as soluble PD1(sPD1)...
Saved in:
Main Authors: | Timothy Hadley (Author), Scott Gillespie (Author), Hillary Espinoza (Author), Jarod Prince (Author), Henning Gronbaek (Author), Shanmuganathan Chandrakasan (Author), Subra Kuguthasan (Author), Vasantha L. Kolachala (Author), Nitika A. Gupta (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased IgD and CD27 Double Negative (DN) B cell population in pediatric onset autoimmune hepatitis
by: Vasantha L. Kolachala, et al.
Published: (2024) -
PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
by: Ke Zhang, et al.
Published: (2022) -
The use of the PD-1/PD-L1 pathway as an immunotherapy in oncological diseases, autoimmune diseases and infectious diseases
by: Dominika Katarzyna Madras, et al.
Published: (2020) -
Autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome in inflammatory bowel diseases
by: Joanna Saganek, et al.
Published: (2023) -
Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
by: Maurizio eCapuozzo, et al.
Published: (2013)